Trials / Unknown
UnknownNCT02576158
HPV Integration Testing for Cervical Cancer Screening
HPV（Human Papillomavirus） Integration Testing for Cervical Cancer Screening
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 12,000 (estimated)
- Sponsor
- Huazhong University of Science and Technology · Academic / Other
- Sex
- Female
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The primary objective is to determine the sensitivity and specificity of the HPV Integration-based cervical screening for detection of high-grade cervical intraepithelial neoplasia (CIN), using colposcopic inspection as the reference method. Lesions will be confirmed as malignant or CIN by colposcopic inspection and histopathologic examination.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | TCT，HPV，colposcopic inspection |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2018-09-01
- Completion
- 2020-04-01
- First posted
- 2015-10-15
- Last updated
- 2017-06-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02576158. Inclusion in this directory is not an endorsement.